共 151 条
[1]
Babitt JL(2006)KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease Am J Kidney Dis 47 S11-1634
[2]
Lin HY(2012)Mechanisms of anemia in chronic kidney disease J Am Soc Nephrol 23 1631-1178
[3]
Winearls CG(1986)Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis Lancet. 2 1175-78
[4]
Oliver DO(1987)Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial N Engl J Med 316 73-2084
[5]
Pippard MJ(2006)Normalization of hemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 355 2071-434
[6]
Reid C(2008)Normal hematocrit cardiac trial a. the normal hematocrit study--follow-up N Engl J Med 358 433-2098
[7]
Downing MR(2006)Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 2085-2908
[8]
Cotes PM(2011)Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience Circulation. 124 2903-590
[9]
Eschbach JW(1998)The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 584-2032
[10]
Egrie JC(2009)A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2019-2850